TransMedics Group (NASDAQ:TMDX): An Affordable Growth Stock With Strong Earnings Momentum
Transmedics Group Inc TMDX
$76.51
▲ +0.50%
(+$0.38)
🔥 High Short Interest
📅 Earnings This Week
Open
$76.50
Prev Close
$76.13
Day Range
$74.87 – $76.92
52W Range
$60.11 – $156.00
Market Cap
$2.64B
P/E (TTM)
15.38
Beta
1.93
EPS (TTM)
$4.23
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-05-02 |
| Shares Out. | 34,560,000 |
| Website | transmedics.com/ ↗ |
| Phone | 19785520900 |
| Employees | 898 |
| Revenue | $173.9M |
| Gross Profit | $101.2M |
| Net Income | $7.3M |
| Free Cash Flow | $151.4M |
| Total Assets | $1.43B |
| Total Liabilities | $940.8M |
| Equity | $494.0M |
About Transmedics Group Inc
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Transmedics Group Inc is a publicly traded company under the ticker symbol TMDX on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
19 analysts (2026-07-01)